FreeStyle Libre Pro
Device Diabetes Care
PDI 00357599715557
General payments
$1,173,425
Research payments
$1,417,669
Through program year 2025, $1,173,425 in general payments and $1,417,669 in research payments were reported against FreeStyle Libre Pro (Diabetes Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $89,242 | 131 |
| 2025 | Research | $408,417 | 10 |
| 2024 | General | $110,365 | 169 |
| 2024 | Research | $85,064 | 19 |
| 2023 | General | $28,660 | 25 |
| 2023 | Research | $304,633 | 78 |
| 2022 | General | $15,958 | 26 |
| 2022 | Research | $4,879 | 23 |
| 2021 | General | $929,200 | 1,179 |
| 2021 | Research | $614,677 | 43 |
Breakdown
The top 5 of 22 recipients; each share is of general payments naming this product in 2025.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,530 general · 173 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.